Genomically Directed Monotherapy
BRE12-158
Phase 2 small_molecule completed
Quick answer
Genomically Directed Monotherapy for Malignant Neoplasm of Breast is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Malignant Neoplasm of Breast
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed